Trial Profile
DPP-4 Inhibitors in Patients With Type 2 Diabetes and Acute Myocardial Infarction:Effects on Platelet Function
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Aug 2020 Status changed from recruiting to completed.
- 10 Feb 2020 Planned End Date changed from 1 Dec 2019 to 31 May 2020.
- 10 Feb 2020 Planned primary completion date changed from 1 Jul 2019 to 31 May 2020.